CAR Peptide
Pulmonary Hypertension, Sepsis, COVID-19
Pre-clinicalActive
Key Facts
Indication
Pulmonary Hypertension, Sepsis, COVID-19
Phase
Pre-clinical
Status
Active
Company
About Vascular Biosciences
Vascular Biosciences is a private, pre-revenue biotech firm founded in 2004 and based in San Diego. The company operates across three synergistic divisions: a pharmaceutical arm developing the CAR peptide for pulmonary hypertension, COVID-19, and sepsis; an interventional device arm with a novel endoarterial biopsy catheter; and a molecular diagnostics arm for analyzing biopsy samples. Its integrated approach aims to diagnose, monitor, and treat vascular diseases with greater precision, though its lead programs remain in pre-clinical and early development stages.
View full company profile